These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 23680006)

  • 1. Post-translational modifications of CFTR: insight into protein trafficking and cystic fibrosis disease.
    Amaral MD; Farinha CM
    FEBS J; 2013 Sep; 280(18):4395. PubMed ID: 23680006
    [No Abstract]   [Full Text] [Related]  

  • 2. Control of cystic fibrosis transmembrane conductance regulator membrane trafficking: not just from the endoplasmic reticulum to the Golgi.
    Farinha CM; Matos P; Amaral MD
    FEBS J; 2013 Sep; 280(18):4396-406. PubMed ID: 23773658
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Defects in processing and trafficking of cystic fibrosis transmembrane conductance regulator.
    Kunzelmann K; Nitschke R
    Exp Nephrol; 2000; 8(6):332-42. PubMed ID: 11014930
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular modelling approaches for cystic fibrosis transmembrane conductance regulator studies.
    Odolczyk N; Zielenkiewicz P
    Int J Biochem Cell Biol; 2014 Jul; 52():39-46. PubMed ID: 24735712
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correctors of the basic trafficking defect of the mutant F508del-CFTR that causes cystic fibrosis.
    Birault V; Solari R; Hanrahan J; Thomas DY
    Curr Opin Chem Biol; 2013 Jun; 17(3):353-60. PubMed ID: 23711435
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CFTR structure and cystic fibrosis.
    Cant N; Pollock N; Ford RC
    Int J Biochem Cell Biol; 2014 Jul; 52():15-25. PubMed ID: 24534272
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cystic fibrosis transmembrane conductance regulator degradation: cross-talk between the ubiquitylation and SUMOylation pathways.
    Ahner A; Gong X; Frizzell RA
    FEBS J; 2013 Sep; 280(18):4430-8. PubMed ID: 23809253
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proteomics and Metabolomics for Cystic Fibrosis Research.
    Liessi N; Pedemonte N; Armirotti A; Braccia C
    Int J Mol Sci; 2020 Jul; 21(15):. PubMed ID: 32751630
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The cystic fibrosis transmembrane regulator forms macromolecular complexes with PDZ domain scaffold proteins.
    Guggino WB
    Proc Am Thorac Soc; 2004; 1(1):28-32. PubMed ID: 16113408
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The DeltaF508 cystic fibrosis mutation impairs domain-domain interactions and arrests post-translational folding of CFTR.
    Du K; Sharma M; Lukacs GL
    Nat Struct Mol Biol; 2005 Jan; 12(1):17-25. PubMed ID: 15619635
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulated trafficking of the CFTR chloride channel.
    Kleizen B; Braakman I; de Jonge HR
    Eur J Cell Biol; 2000 Aug; 79(8):544-56. PubMed ID: 11001491
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cystic fibrosis.
    Rowe SM; Miller S; Sorscher EJ
    N Engl J Med; 2005 May; 352(19):1992-2001. PubMed ID: 15888700
    [No Abstract]   [Full Text] [Related]  

  • 13. Rescuing cystic fibrosis transmembrane conductance regulator (CFTR)-processing mutants by transcomplementation.
    Cormet-Boyaka E; Jablonsky M; Naren AP; Jackson PL; Muccio DD; Kirk KL
    Proc Natl Acad Sci U S A; 2004 May; 101(21):8221-6. PubMed ID: 15141088
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulation of deltaF508 cystic fibrosis transmembrane regulator trafficking and function with 4-phenylbutyrate and flavonoids.
    Lim M; McKenzie K; Floyd AD; Kwon E; Zeitlin PL
    Am J Respir Cell Mol Biol; 2004 Sep; 31(3):351-7. PubMed ID: 15191910
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rescue of functional delF508-CFTR channels in cystic fibrosis epithelial cells by the alpha-glucosidase inhibitor miglustat.
    Norez C; Noel S; Wilke M; Bijvelds M; Jorna H; Melin P; DeJonge H; Becq F
    FEBS Lett; 2006 Apr; 580(8):2081-6. PubMed ID: 16546175
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Misfolded proteins in the endoplasmic reticulum.
    Perlmutter DH
    Lab Invest; 1999 Jun; 79(6):623-38. PubMed ID: 10378505
    [No Abstract]   [Full Text] [Related]  

  • 17. S-nitrosoglutathione increases cystic fibrosis transmembrane regulator maturation.
    Zaman K; McPherson M; Vaughan J; Hunt J; Mendes F; Gaston B; Palmer LA
    Biochem Biophys Res Commun; 2001 Jun; 284(1):65-70. PubMed ID: 11374871
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Introduction to section III: biochemical methods to study CFTR protein.
    Amaral MD; Lukacs GL
    Methods Mol Biol; 2011; 741():213-8. PubMed ID: 21594787
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural changes of CFTR R region upon phosphorylation: a plastic platform for intramolecular and intermolecular interactions.
    Bozoky Z; Krzeminski M; Chong PA; Forman-Kay JD
    FEBS J; 2013 Sep; 280(18):4407-16. PubMed ID: 23826884
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disease-associated mutations in cytoplasmic loops 1 and 2 of cystic fibrosis transmembrane conductance regulator impede processing or opening of the channel.
    Seibert FS; Jia Y; Mathews CJ; Hanrahan JW; Riordan JR; Loo TW; Clarke DM
    Biochemistry; 1997 Sep; 36(39):11966-74. PubMed ID: 9305991
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.